The Clinical Significance of Serum Anti-Titin Antibodies and Anti-Acetylcholine Receptor Antibodies in Patients with Myasthenia Gravis

Shu ZHU,Chen-yi WAN,Fei ZHAO,Min ZHU,Dao-jun HONG,Hui WAN

DOI: https://doi.org/10.3969/j.issn.1006-2963.2012.06.010

2012-01-01

Abstract:Objective To investigate the clinical significance of serum anti-titin antibodies(titin-Ab) and anti-acetylcholine receptor antibodies(AChRAb) in patients with myasthenia gravis(MG).Methods To detect titin-Ab and AChRAb with enzyme linked immunosorbent assay(ELISA) in the sera from 90 cases of MG group and 30 cases of control group.Results The positive rates of titin-Ab and AChRAb(76.7%,54.5%) in MG group were significantly higher than those of control group(χ2=41.667,P=0.000;χ2=21.017,P=0.000).The sensitivities of titin-Ab and AChRAb in MG patients were 54.5% and 76.7% respectively.The sensitivity of parallel test was 89.4%.The positive rates of titin-Ab were significantly higher in MG with thymoma(80.0%) and late-onset MG(72.5%) subgroups than in the MG without thymoma(47.1%,χ2=6.771,P=0.009) and early-onset MG subgroups(40.0%,χ2=9.46,P=0.002).The positive rates of both antibodies in generalized MG patients(69.2%,90.4%)were higher than those in ocular MG patients(34.2%,χ2=10.856,P=0.001;57.9%,χ2=12.956,P≤0.000).There was no significant difference in the positive rate of titin-Ab(33.3%,56.8%)and AChRAb(55.6%,79%)between MG patients with and without hyperthyroidism(χ2=1.797,P=0.19;χ2=2.491,P=0.063).Conclusions Titin-Ab and AChRAb can be used as indicators of the diagnosis of MG.Testing for a combination of titin-Ab and AChRAb gives higher sensitivity for the detection of MG than testing each antibody alone.The more severe the MG was,the higher positive rates of titin-Ab and AChRAb were.Titin-Ab and AChRAb titers were not correlated in MG patients.